GENinCode PLC

As of December 31, 2025, GENinCode PLC carries a market capitalization of 688.52M, placing it among publicly traded companies globally. Its enterprise value stands at 613.62M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

GENinCode PLC's next confirmed earnings release is scheduled for June 8, 2027.

As of December 31, 2025, GENinCode PLC has 286.88M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, GENinCode PLC maintains a current ratio of 0.93, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, GENinCode PLC's stock has declined approximately 82.64% over the past 52 weeks. The 50-day moving average sits at 0.82, while the 200-day moving average is 1.02.

As of December 31, 2025, GENinCode PLC holds 89.50M in cash and equivalents against 14.60M in total debt, resulting in a net debt position of -82.70M. Total book value stands at 12.40M, with working capital of -15.80M providing operational flexibility.